{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:36:57Z","timestamp":1776728217328,"version":"3.51.2"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.beem.2021.101514","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T01:46:00Z","timestamp":1615427160000},"page":"101514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Updates in the outcomes of radiation therapy for Cushing\u2019s disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Monica Livia","family":"Gheorghiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.beem.2021.101514_bib1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/gs.2019.11.03","article-title":"Cardiovascular risk and mortality in patients with active and treated hypercortisolism","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ecl.2018.02.008","article-title":"Cushing\u2019s syndrome in pediatrics: an update","volume":"47","author":"Lodish","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2021.101514_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.wneu.2020.06.138","article-title":"Cushing syndrome caused by ectopic adrenocorticotropic hormone-secreting pituitary adenomas: case report and literature review","volume":"142","author":"Sun","year":"2020","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib5","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2021.101514_bib6","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101514_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/17446651.2020.1802243","article-title":"Management of patients with persistent or recurrent Cushing\u2019s disease after initial pituitary surgery","volume":"15","author":"Capatina","year":"2020","journal-title":"Expet Rev Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib8","doi-asserted-by":"crossref","first-page":"101269","DOI":"10.1016\/j.beem.2019.04.003","article-title":"The risk\/benefit ratio of radiotherapy in pituitary tumors","volume":"33","author":"Minniti","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.wneu.2015.01.038","article-title":"Nelson syndrome: update on therapeutic approaches","volume":"83","author":"Azad","year":"2015","journal-title":"World Neurosurg"},{"issue":"9996","key":"10.1016\/j.beem.2021.101514_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4183\/aeb.2017.476","article-title":"Stereotactic radiation therapy in pituitary adenomas, is it better than conventional radiation therapy?","volume":"13","author":"Gheorghiu","year":"2017","journal-title":"Acta Endocrinol (Buchar )"},{"key":"10.1016\/j.beem.2021.101514_bib12","unstructured":"Varlamov EV, Langlois F, Vila G, Fleseriu M. Cardiovascular risk assessment, thromboembolism and infection prevention in Cushing\u2019s syndrome - a practical approach. Feb 1:EJE-20-1309 R1 doi: 10.1530\/EJE-20-1309.2021."},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/cen.14123","article-title":"Cabergoline may act as a radioprotective agent in Cushing\u2019s disease","volume":"92","author":"Thakkar","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib14","first-page":"1486","article-title":"Results of gamma knife surgery for Cushing\u2019s disease","volume":"119","author":"Sheehan","year":"2013","journal-title":"J\u00a0Neurosurg"},{"issue":"9","key":"10.1016\/j.beem.2021.101514_bib15","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2008-2772","article-title":"Long-term results of stereotactic radiosurgery in secretory pituitary adenomas","volume":"94","author":"Castinetti","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101514_bib16","article-title":"Efficacy and safety of stereotactic radiotherapy in Cushing\u2019s disease: a single center experience","author":"Apaydin","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"10.1016\/j.beem.2021.101514_bib17","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2017-01385","article-title":"Stereotactic radiosurgery for Cushing disease: results of an international, multicenter study","volume":"102","author":"Mehta","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/a-1066-4592","article-title":"Updates in the medical treatment of pituitary adenomas","volume":"52","author":"Gheorghiu","year":"2020","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.beem.2021.101514_bib19","doi-asserted-by":"crossref","first-page":"D9","DOI":"10.1530\/EJE-19-0092","article-title":"Radiotherapy as a tool for the treatment of Cushing\u2019s disease","volume":"180","author":"Castinetti","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-007-9344-0","article-title":"Long-term follow-up results of postoperative radiation therapy for Cushing\u2019s disease","volume":"84","author":"Minniti","year":"2007","journal-title":"J\u00a0Neuro Oncol"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1990.tb03883.x","article-title":"Long-term follow-up of low-dose external pituitary irradiation for Cushing\u2019s disease","volume":"33","author":"Littley","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib23","first-page":"935","article-title":"Long term follow-up of Cushing\u2019s disease treated with reserpine and pituitary irradiation","volume":"75","author":"Murayama","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing\u2019s disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-8140(96)91807-1","article-title":"Role of radiation therapy in clinical hormonally-active pituitary adenomas","volume":"41","author":"Tsang","year":"1996","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4158\/EP15922.RA","article-title":"Predictors of biochemical remission and recurrence after surgical and radiation treatments of Cushing disease: a systematic review and meta-analysis","volume":"22","author":"Abu Dabrh","year":"2016","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-017-2530-9","article-title":"Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review","volume":"135","author":"van Westrhenen","year":"2017","journal-title":"J\u00a0Neuro Oncol"},{"issue":"8","key":"10.1016\/j.beem.2021.101514_bib29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3109\/02841861003782025","article-title":"Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden","volume":"49","author":"Norberg","year":"2010","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6838","key":"10.1016\/j.beem.2021.101514_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.304.6838.1343","article-title":"Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma","volume":"304","author":"Brada","year":"1992","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10143-019-01134-z","article-title":"Pituitary adenomas and neuropsychological status: a systematic literature review","volume":"43","author":"Pertichetti","year":"2020","journal-title":"Neurosurg Rev"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11102-016-0783-5","article-title":"Updates in outcomes of stereotactic radiation therapy in acromegaly","volume":"20","author":"Gheorghiu","year":"2017","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9010031","article-title":"Proton and heavy particle intracranial radiosurgery","volume":"9","author":"Lehrer","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ecl.2018.01.002","article-title":"Outcomes of pituitary radiation for Cushing\u2019s disease","volume":"47","author":"Ironside","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2021.101514_bib37","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/j.wneu.2018.01.057","article-title":"CyberKnife radiosurgery in the multimodal management of patients with Cushing disease","volume":"112","author":"Moore","year":"2018","journal-title":"World Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib38","first-page":"980","article-title":"Gamma Knife surgery for Cushing\u2019s disease","volume":"106","author":"Jagannathan","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"12","key":"10.1016\/j.beem.2021.101514_bib39","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4158\/EP161512.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: diagnosis of recurrence in Cushing disease","volume":"22","author":"Fleseriu","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/eje.1.02323","article-title":"Gamma knife radiosurgery is a successful adjunctive treatment in Cushing\u2019s disease","volume":"156","author":"Castinetti","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11102-014-0584-7","article-title":"Gamma knife radiosurgery for Cushing\u2019s disease and Nelson\u2019s syndrome","volume":"18","author":"Marek","year":"2015","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jc.2007-1220","article-title":"Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas","volume":"93","author":"Petit","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijrobp.2014.06.068","article-title":"Outcomes of proton therapy for patients with functional pituitary adenomas","volume":"90","author":"Wattson","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5\u20136","key":"10.1016\/j.beem.2021.101514_bib44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000083476","article-title":"The efficacy of linear accelerator radiosurgery in the management of patients with Cushing\u2019s disease","volume":"82","author":"Devin","year":"2004","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/cncr.22128","article-title":"Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study","volume":"107","author":"Voges","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jocn.2013.04.007","article-title":"Cushing\u2019s disease: a single centre\u2019s experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy","volume":"21","author":"Wilson","year":"2014","journal-title":"J\u00a0Clin Neurosci"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rpor.2014.09.004","article-title":"Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas","volume":"21","author":"Minniti","year":"2016","journal-title":"Rep Practical Oncol Radiother"},{"key":"10.1016\/j.beem.2021.101514_bib48","first-page":"1","article-title":"Early versus late Gamma Knife radiosurgery for Cushing\u2019s disease after prior resection: results of an international, multicenter study","author":"Bunevicius","year":"2020","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2021.101514_bib49","first-page":"1","article-title":"Outcomes of Cushing\u2019s disease following Gamma Knife radiosurgery: effect of a center\u2019s growing experience and era of treatment","author":"Bunevicius","year":"2020","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2021.101514_bib50","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/j.wneu.2018.05.067","article-title":"Technique of whole-sellar stereotactic radiosurgery for Cushing disease: results from a multicenter, International Cohort Study","volume":"116","author":"Shepard","year":"2018","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2265.1989.tb01255.x","article-title":"Megavoltage pituitary irradiation in the management of Cushing\u2019s disease and Nelson\u2019s syndrome: long-term follow-up","volume":"31","author":"Howlett","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2021.101514_bib52","doi-asserted-by":"crossref","first-page":"106151","DOI":"10.1016\/j.clineuro.2020.106151","article-title":"Gamma knife radiosurgery in patients with Cushing\u2019s disease: comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma","volume":"197","author":"Kara","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11060-018-03078-8","article-title":"The role of Crooke\u2019s changes in recurrence and remission after gamma knife radiosurgery","volume":"142","author":"Cordeiro","year":"2019","journal-title":"J\u00a0Neuro Oncol"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib54","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/EJE-09-0493","article-title":"Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy","volume":"161","author":"Swords","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"Suppl","key":"10.1016\/j.beem.2021.101514_bib55","first-page":"31","article-title":"Gamma Knife surgery after fractionated radiotherapy for acromegaly","volume":"105","author":"Landolt","year":"2006","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11060-018-2817-5","article-title":"Repeat stereotactic radiosurgery for Cushing\u2019s disease: outcomes of an international, multicenter study","volume":"138","author":"Mehta","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0360-3016(89)90385-4","article-title":"Repeat megavoltage irradiation of pituitary and suprasellar tumors","volume":"17","author":"Flickinger","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00066-002-0826-x","article-title":"Radiation therapy in the multimodal treatment approach of pituitary adenoma","volume":"178","author":"Becker","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.beem.2021.101514_bib59","article-title":"Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study","author":"Cordeiro","year":"2018","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-010-0172-2","article-title":"Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases","volume":"98","author":"Hayashi","year":"2010","journal-title":"J\u00a0Neuro Oncol"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(18)30659-4","article-title":"Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study","volume":"20","author":"Wolf","year":"2019","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib62","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jc.2016-3402","article-title":"Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary\/sellar lesions","volume":"102","author":"Burman","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.beem.2021.101514_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.wneu.2011.09.010","article-title":"Neurocognitive changes in pituitary adenoma patients after gamma knife radiosurgery: a preliminary study","volume":"78","author":"Tooze","year":"2012","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2021.101514_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/neuros\/nyz159","article-title":"Radiosurgical management of patients with persistent or recurrent Cushing disease after prior transsphenoidal surgery: a management algorithm based on a 25-year experience","volume":"86","author":"Hughes","year":"2020","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.beem.2021.101514_bib65","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/neuros\/nyx426","article-title":"A\u00a0long-term study of the treatment of Nelson\u2019s syndrome with gamma knife radiosurgery","volume":"83","author":"Caruso","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2021.101514_bib66","first-page":"1","article-title":"Gamma Knife radiosurgery for the treatment of Nelson\u2019s syndrome: a multicenter, international study","author":"Cordeiro","year":"2019","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/EJE-08-0687","article-title":"Gamma knife stereotactic radiosurgery of Nelson syndrome","volume":"160","author":"Vik-Mo","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2021.101514_bib68","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jocn.2013.12.026","article-title":"Nelson\u2019s syndrome: single centre experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy","volume":"21","author":"Wilson","year":"2014","journal-title":"J\u00a0Clin Neurosci"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib69","first-page":"988","article-title":"Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy","volume":"106","author":"Mauermann","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib70","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.surg.2006.12.003","article-title":"Nelson\u2019s syndrome after bilateral adrenalectomy for Cushing\u2019s disease","volume":"141","author":"Gil-Cardenas","year":"2007","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib71","first-page":"165","article-title":"The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing\u2019s syndrome","volume":"80","author":"Jenkins","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2021.101514_bib72","first-page":"1493","article-title":"Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing\u2019s disease on the incidence of Nelson\u2019s syndrome","volume":"119","author":"Mehta","year":"2013","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib73","first-page":"e33","article-title":"The novel use of stereotactic radiotherapy for remnant adrenal tissue in Nelson syndrome","volume":"6","author":"Martirossian","year":"2020","journal-title":"AACE Clin Case Rep"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib74","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-016-0710-y","article-title":"Target delineation and optimal radiosurgical dose for pituitary tumors","volume":"11","author":"Minniti","year":"2016","journal-title":"Radiat Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.beem.2021.101514_bib75","first-page":"422","article-title":"Gamma knife radiosurgery in the treatment of Cushing disease: long-term results","volume":"97","author":"Kobayashi","year":"2002","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib76","first-page":"532","article-title":"Upfront Gamma Knife radiosurgery for Cushing\u2019s disease and acromegaly: a multicenter, international study","volume":"131","author":"Gupta","year":"2018","journal-title":"J\u00a0Neurosurg"},{"issue":"10","key":"10.1016\/j.beem.2021.101514_bib77","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1445-5994.2012.02903.x","article-title":"Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience","volume":"42","author":"Wein","year":"2012","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.beem.2021.101514_bib78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11102-013-0466-4","article-title":"Encouraging efficacy of modern conformal fractionated radiotherapy in patients with uncured Cushing\u2019s disease","volume":"17","author":"Budyal","year":"2014","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2021.101514_bib79","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","article-title":"Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients","volume":"62","author":"Colin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:06Z","timestamp":1761497826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1521690X21000312"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101514","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in the outcomes of radiation therapy for Cushing\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101514"}}